GlassScriptPhysician profile
James Garrett Webster
NPI 1497172787
$4,445.05
in general payments reported to CMS, 2019-2025
23 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $508 · 2021: $416 · 2022: $281 · 2023: $489 · 2024: $1,132 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,758 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,758.44 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,405.16 | 2019-2025 | Ngenuity, Clareon, Unity |
| Sun Pharmaceutical Industries INC. | $374.02 | 2019-2025 | Cequa |
| Sight Sciences, INC. | $284.40 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Astellas Pharma US INC | $146.88 | 2024-2025 | Izervay |
| Oyster Point Pharma, INC. | $142.69 | 2023-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $130.24 | 2019-2021 | |
| Ocular Therapeutix, INC. | $107.54 | 2020-2024 | Dextenza |
| Aerie Pharmaceuticals, INC. | $105.38 | 2020-2021 | |
| Abbvie INC. | $93.29 | 2023-2025 | Durysta |
| Biotissue Holdings INC. | $87.26 | 2020-2024 | |
| Tarsus Pharmaceuticals, INC. | $84.78 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $82.54 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Allergan, INC. | $75.89 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $56.09 | 2020-2021 | |
| New World Medical,INC. | $51.22 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $41.54 | 2025 | Catalys System |
| Thea Pharma INC. | $40.63 | 2023-2025 | Iyuzeh |
| Rayner Intraocular Lenses Limited | $32.49 | 2025 | Omidria |
| Harrow Eye, LLC | $25.19 | 2025 | Vevye |
| Horizon Therapeutics Plc | $23.55 | 2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $21.51 | 2021 | |
| Rxsight INC | $19.16 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Lkc Technologies, INC. | $13.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Webster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.